Turn Intangible Assets from 2010 to 2026
| TTRX Stock | 3.94 0.23 6.20% |
Intangible Assets | First Reported 2010-12-31 | Previous Quarter 821.9 K | Current Value 875.5 K | Quarterly Volatility 28.6 K |
Check Turn Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Turn Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 24.5 K, Interest Income of 24.5 K or Depreciation And Amortization of 50.3 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.0. Turn financial statements analysis is a perfect complement when working with Turn Therapeutics Valuation or Volatility modules.
Check out the analysis of Turn Therapeutics Correlation against competitors. Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Turn Stock Analysis
When running Turn Therapeutics' price analysis, check to measure Turn Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Turn Therapeutics is operating at the current time. Most of Turn Therapeutics' value examination focuses on studying past and present price action to predict the probability of Turn Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Turn Therapeutics' price. Additionally, you may evaluate how the addition of Turn Therapeutics to your portfolios can decrease your overall portfolio volatility.